Picture of Larimar Therapeutics logo

LRMR — Larimar Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Larimar Therapeutics Inc Selected By FDA To Participate In Start Pilot Program For Nomlabofusp In Friedreich's Ataxia

Larimar Therapeutics Inc  LRMR.O :
    * LARIMAR THERAPEUTICS INC: SELECTED BY FDA TO PARTICIPATE
IN
START PILOT PROGRAM FOR NOMLABOFUSP IN FRIEDREICH'S ATAXIA

Source text for Eikon:  ID:nGNX5LyB6y 
Further company coverage:  LRMR.O

Recent news on Larimar Therapeutics

See all news